ByTrending Posts
Could Johnson & Johnson’s MARIPOSA Trial with RYBREVANT®…
Key Highlights: Clinical Breakthrough in EGFR-Mutated NSCLCJohnson & Johnson’s Innovative Medicine segment has announced positive results from the…
Can Novo Nordisk’s New Semaglutide and Obesity Pipeline…
Key Highlights: Scientific Momentum at EASD 2025Novo Nordisk will present 35 abstracts across its diabetes and obesity portfolio…
Could Pfizer and BioNTech’s LP.8.1-Adapted COMIRNATY® Redefine COVID-19…
Key Insights: Robust Phase 3 Findings for High-Risk PopulationsThe topline results from the Phase 3 clinical trial included…
Will Merck’s CAPVAXIVE® 21-Valent Vaccine Set a New…
Key Highlights Promising Phase 3 Data from STRIDE-13 TrialMerck announced that CAPVAXIVE demonstrated robust immunogenicity and safety in…
Could Sanofi’s One-Time Gene Therapy SAR402663 Transform Treatment…
Key Highlights A Major Step Forward in Retinal Disease InnovationThe FDA’s Fast Track designation underscores the urgent need…
Is Lilly’s “TuneLab” the Breakthrough AI Collaboration Model…
Key Highlights A bold move: Lilly democratizes AI for biotechEli Lilly has launched TuneLab, a novel AI platform…
Can Gilead’s Twice-Yearly Yeytuo® (Lenacapavir) Redefine HIV Prevention…
Key Insights: A Historic European Approval That Expands Prevention Choices The European Commission granted marketing authorization for Gilead’s…
Can Amgen and Kyowa Kirin’s Rocatinlimab Redefine Atopic…
Key Insights: Breakthrough Data From ASCEND Long-Term Extension Amgen and Kyowa Kirin released top-line results from the global…
Lilly’s Jaypirca Shows Strong Phase 3 Results in…
Eli Lilly and Company (NYSE: LLY) announced positive topline results from the Phase 3 BRUIN CLL-313 trial evaluating…
Trending Posts
Latest Stories
Eli Lilly Announces $6 Billion Pharmaceutical Manufacturing Campus in Huntsville, Alabama
Huntsville, AL – Eli Lilly and Company today announced plans to construct a $6 billion…
Novartis Canada Receives Positive Funding Recommendations for Scemblix® for Chronic Myeloid Leukemia
Montreal, QC – Novartis Canada today announced that the Institut national d’excellence en santé et…
Novartis Announces Agreement with U.S. Government to Support Affordable Access to Medicines
Basel, Switzerland – Novartis, a global leader in innovative medicines, today announced it has reached…
Penguin AI Raises $29.7 Million to Transform Healthcare Administration with Advanced AI
Palo Alto, CA Penguin AI, a healthcare technology company focused on using artificial intelligence to…
Gallery
